Delivery Order SPE2DB24D2205-SPE2DB25FEHTS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages) with a contract value of $16,251.94. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 28, 2025, with an ultimate completion date of December 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $12,518.91. The order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $3,329.04. The delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside, competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.19 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count package). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by June 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for supply of BRILINTA 60 mg tablets (60-count packages) with a ceiling value of $2,125.24. This non-set-aside, firm fixed-price delivery order is scheduled for ultimate completion by December 5, 2025, with performance originating from the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.80 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count package) with an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count units) on September 26, 2025, with a ceiling value of $3,626.64 and completion deadline of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a $3,694.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 90 MG, an antiplatelet medication used to reduce the risk of thrombotic cardiovascular events. The award was issued on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 60 mg tablets (60-count) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed price delivery order, valued at $1,516.38, represents a non-competitive set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,763.44 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count) on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BRILINTA is a antiplatelet medication commonly used in military and veteran healthcare...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHTSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BRILINTA 90 mg tablets (60-count) with a ceiling value of $7,078.10 under a firm fixed-price contract type. The order was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location, which serves as the place of performance. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime pharmaceutical contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. BRILINTA, an antiplatelet medication, represents one of the specialized pharmaceutical products available through this expansive contracting mechanism designed to ensure consistent pharmaceutical support across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/18/25 |